MedPath

Effects of Kihito on cognitive functions in Alzheimer's disease patients

Not Applicable
Conditions
Alzheimer&#39
s disease
Registration Number
JPRN-UMIN000023509
Lead Sponsor
niversity of Toyama
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Persons whose MMSE score is below 14 points.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
At the pre and post (for 16 weeks) administration of kKihito, these tests of cognitive functions are done; Mini Mental State Examination (MMSE)and Repeatable Battery for the Assessment (RBANS).
Secondary Outcome Measures
NameTimeMethod
analysis of the blood
© Copyright 2025. All Rights Reserved by MedPath